Results 261 to 270 of about 14,877 (300)

A Risk-Benefit Assessment of Abciximab in Angioplasty

Drug Safety, 1999
Advances in percutaneous coronary intervention (PCI) have allowed procedures to be performed on a variety of patients with a spectrum of challenging coronary anatomy. Abciximab has permitted further expansion and has made the procedure safer. Abciximab is a chimerised murine monoclonal antibody directed against the platelet glycoprotein (GP) IIb-IIIa ...
openaire   +3 more sources

Abciximab and Alveolar Hemorrhage

New England Journal of Medicine, 1998
Homayoun Khanlou, Shahriar Yazdanfar, Glenn Eiger   +2 more
openaire   +3 more sources

Abciximab-associated pseudothrombocytopenia

The American Journal of Medicine, 2002
Randy L. Hamill, Ronald L. Wool, Teresa A. Coleman   +2 more
openaire   +2 more sources

Emergent carotid stenting and intra-arterial abciximab in acute ischemic stroke due to tandem occlusion

British Journal of Neurosurgery, 2017
F. Al-Mufti, K. Amuluru, N. Manning, I. Khan, L. Peeling, C. Gandhi, C. Prestigiacomo, Galyna Pushchinska, D. Fiorella, H. Woo   +9 more
semanticscholar   +1 more source

In situ administration of abciximab for thrombus resolution during intracranial bypass surgery: case report.

Journal of Neurosurgery, 2018
Ian A. Buchanan, Brian T. Lee, A. Amar, S. Giannotta   +3 more
semanticscholar   +1 more source

αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells.

Current Drug Targets, 2015
J. Konończuk, A. Surażyński, U. Czyżewska, Izabela Prokop, M. Tomczyk, J. Pałka, W. Miltyk   +6 more
semanticscholar   +1 more source

Abciximab vials as multidose containers

American Journal of Health-System Pharmacy, 1998
Linda L. Norton, William P. Yee
openaire   +3 more sources

Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.

American Heart Journal, 2015
F. Prati, E. Romagnoli, U. Limbruno, T. Pawlowski, S. Fedele, L. Gatto, L. Di Vito, A. Pappalardo, V. Ramazzotti, A. Picchi, A. Trivisonno, Laura Materia, Piotre Pfiatkosky, G. Paoletti, V. Marco, L. Tavazzi, F. Versaci, G. Stone   +17 more
semanticscholar   +1 more source

Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms

Journal of NeuroInterventional Surgery, 2015
M. Levitt, K. Moon, F. Albuquerque, C. Mulholland, M. Kalani, C. McDougall   +5 more
semanticscholar   +1 more source

High-bolus dose tirofiban compared with abciximab in primary percutaneous coronary intervention: a propensity score-matched outcome study.

EuroIntervention, 2015
D. Austin, D. Mackay, R. Morley, J. Christie, Barry Hennigan, M. de Belder, J. Pell, K. Oldroyd   +7 more
semanticscholar   +1 more source